Amalgamated Bank’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
SAM
Amalgamated Bank's PRAX Position: Q2 2026 in Review
Amalgamated Bank reduced its Praxis Precision Medicines (PRAX) stake by 3.7% in Q2 2026, selling an estimated $8.23K and leaving 682 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #1568.
Amalgamated Bank first reported a position in PRAX in Q1 2022 and has held it in 14 quarters since. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Amalgamated Bank held 682 shares of Praxis Precision Medicines worth $228K as of Q2 2026.
- Amalgamated Bank sold 26 Praxis Precision Medicines shares in Q2 2026, an estimated $8.23K.
- Praxis Precision Medicines made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1568 holding.
- Amalgamated Bank first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 14 quarters since.
- 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.